Clinical Trial Update: Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of enzastaurin in newly diagnosed glioblastoma multiforme and gliosarcoma completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioblastoma Multiforme
• Gliosarcoma

Drugs mentioned

• Enzastaurin (enzastaurin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Glioblastoma, Glioblastoma Multiforme | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-08-06